实时全球研报
Bystronic Feedback from Conference Call with CEO / CFO
研报英文原文证据摘录
Bystronic Feedback from Conference Call with CEO / CFO
d) (CHF)
focus on more attractive niche markets with structural growth angles, such has
From To % ch Cons.
semiconductors and medtech. Bending machines were mentioned to be seeing solid 12/26E (12.16) (12.51) NM (9.42)
demand, while laser machines and automation solutions were lagging. The transition 12/27E (4.82) (4.88) NM 0.98
away from single machine vendors toward automated solution providers is taking longer 12/28E 2.08 2.06 -1 1.59
than expected, with a delay of 12-14 months according to management, and is further
delayed by conservative accounting method. Tommaso Operto, CFA
Analyst
tommaso.operto@ubs.com
Cash flow looks set to improve in H2
+41-44-239 2049
Operating FCF saw material deterioration from -CHF23m in H1 25 to -CHF56.6m. This
Sebastian Vogel, CFAwas in part driven by NWC drag from higher receivables and inventories. Receivables
however - linked to the Rofin acquisition - should normalize in H2 according to sebastian.vogel@ubs.com
management and no similar cash outflow in H2 is expected. Net cash overall came down +41-44 239 90 45
to CHF257m (around 62% of market cap), and already includes CHF42m cash out for
the Rofin acquisition. The company is seeing pricing pressure, mostly in Asia, but also in
Europe from established players. Yet, the mid-term EBIT margin target remains 5-7%
assuming top line recovers, as automation lines for instance are much less competitive
than single machines, and further supported by customers starting to demand more
premium machines again.
Valuation: Remain Neutral
Our price target of CHF140 is based on a three-stage DCF model, where we raise our
WACC by 20bps to 8.3%, but keep t-sales growth / t-EBIT margin unchanged at 1.5% /
3.0%.
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器